Secondary stroke prevention: challenges and solutions

References

• SaccoRLKasnerSEBroderickJPAmerican Heart Association Stroke Council, Council on Cardiovascular Surgery and AnesthesiaCouncil on Cardiovascular Radiology and InterventionCouncil on Cardiovascular and Stroke NursingAn updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke AssociationStroke20134472064208923652265
   PubMed Web of Science ®Google Scholar
• MozaffarianDBenjaminEJGoASAmerican Heart Association Statistics Committee and Stroke Statistics SubcommitteeHeart disease and stroke statistics – 2015 update: a report from the American Heart AssociationCirculation20151314e29e32225520374
   PubMed Web of Science ®Google Scholar
• O’DonnellMJXavierDLiuLINTERSTROKE investigatorsRisk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control studyLancet2010376973511212320561675
   PubMed Web of Science ®Google Scholar
• LacklandDTRoccellaEJDeutschAFAmerican Heart Association Stroke CouncilCouncil on Cardiovascular and Stroke NursingCouncil on Quality of Care and Outcomes ResearchCouncil on Functional Genomics and Translational BiologyFactors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke AssociationStroke201445131535324309587
   PubMed Web of Science ®Google Scholar
• BamfordJSandercockPDennisMBurnJWarlowCClassification and natural history of clinically identifiable subtypes of cerebral infarctionLancet19913378756152115261675378
   PubMed Web of Science ®Google Scholar
• KernanWNOvbiageleBBlackHRAmerican Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Peripheral Vascular DiseaseGuidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke AssociationStroke20144572160223624788967
   PubMed Web of Science ®Google Scholar
• AdamsHPJrBendixenBHKappelleLJClassification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke TreatmentStroke199324135417678184
   PubMed Web of Science ®Google Scholar
• AyHFurieKLSinghalASmithWSSorensenAGKoroshetzWJAn evidence-based causative classification system for acute ischemic strokeAnn Neurol200558568869716240340
   PubMed Web of Science ®Google Scholar
• AyHBennerTArsavaEMA computerized algorithm for etiologic classification of ischemic stroke: the Causative Classification of Stroke SystemStroke200738112979298417901381
   PubMed Web of Science ®Google Scholar
• GutierrezJKochSDongCRacial and ethnic disparities in stroke subtypes: a multiethnic sample of patients with strokeNeurol Sci2014354877582
   Web of Science ®Google Scholar
• SchneiderATKisselaBWooDIschemic stroke subtypes: a population-based study of incidence rates among blacks and whitesStroke20043571552155615155974
   PubMed Web of Science ®Google Scholar
• Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. The French Study of Aortic Plaques in Stroke GroupN Engl J Med199633419121612218606716
   PubMed Web of Science ®Google Scholar
• ChimowitzMILynnMJHowlett-SmithHWarfarin-Aspirin Symptomatic Intracranial Disease Trial InvestigatorsComparison of warfarin and aspirin for symptomatic intracranial arterial stenosisN Engl J Med2005352131305131615800226
   PubMed Web of Science ®Google Scholar
• BrottTGHobsonRW2ndHowardGCREST InvestigatorsStenting versus endarterectomy for treatment of carotid-artery stenosisN Engl J Med20103631112320505173
   PubMed Web of Science ®Google Scholar
• Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II StudyLancet199434388996876917907677
   PubMed Web of Science ®Google Scholar
• HommaSThompsonJLPullicinoPMWARCEF InvestigatorsWarfarin and aspirin in patients with heart failure and sinus rhythmN Engl J Med2012366201859186922551105
   PubMed Web of Science ®Google Scholar
• JugduttBISivaramCAProspective two-dimensional echocardiographic evaluation of left ventricular thrombus and embolism after acute myocardial infarctionJ Am Coll Cardiol19891335545642918160
   PubMed Web of Science ®Google Scholar
• PettyGWKhandheriaBKWhisnantJPSicksJDO’FallonWMWiebersDOPredictors of cerebrovascular events and death among patients with valvular heart disease: a population-based studyStroke200031112628263511062286
   PubMed Web of Science ®Google Scholar
• GanRSaccoRLKargmanDERobertsJKBoden-AlbalaBGuQTesting the validity of the lacunar hypothesis: the Northern Manhattan Stroke Study experienceNeurology1997485120412119153444
   PubMed Web of Science ®Google Scholar
• FisherCMLacunar strokes and infarcts: a reviewNeurology19823288718767048128
   PubMed Web of Science ®Google Scholar
• RitterMAKochhäuserSDuningTOccult atrial fibrillation in cryptogenic stroke: detection by 7-day electrocardiogram versus implantable cardiac monitorsStroke20134451449145223449264
   PubMed Web of Science ®Google Scholar
• SannaTDienerHCPassmanRSCRYSTAL AF InvestigatorsCryptogenic stroke and underlying atrial fibrillationN Engl J Med2014370262478248624963567
   PubMed Web of Science ®Google Scholar
• FavillaCGIngalaEJaraJPredictors of finding occult atrial fibrillation after cryptogenic strokeStroke20154651210121525851771
   PubMed Web of Science ®Google Scholar
• ArboixAMartí-VilaltaJLLacunar strokeExpert Rev Neurother20099217919619210194
   PubMed Web of Science ®Google Scholar
• KasnerSEChimowitzMILynnMJWarfarin Aspirin Symptomatic Intracranial Disease Trial InvestigatorsPredictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosisCirculation2006113455556316432056
   PubMed Web of Science ®Google Scholar
• LavalléePCLabreucheJFailleDLacunar-BICHAT InvestigatorsCirculating markers of endothelial dysfunction and platelet activation in patients with severe symptomatic cerebral small vessel diseaseCerebrovasc Dis201336213113824029712
   PubMed Web of Science ®Google Scholar
• DeplanqueDLavalleePCLabreucheJLacunar-BICHAT InvestigatorsCerebral and extracerebral vasoreactivity in symptomatic lacunar stroke patients: a case-control studyInt J Stroke20138641342122336034
   PubMed Web of Science ®Google Scholar
• SPS3 InvestigatorsBenaventeORHartRGEffects of clopidogrel added to aspirin in patients with recent lacunar strokeN Engl J Med2012367981782522931315
   PubMed Web of Science ®Google Scholar
• JohnstonSCSidneySBernsteinALGressDRA comparison of risk factors for recurrent TIA and stroke in patients diagnosed with TIANeurology200360228028512552045
   PubMed Web of Science ®Google Scholar
• Antithrombotic Trialists’ (ATT) CollaborationBaigentCBlackwellLAspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trialsLancet200937396781849186019482214
   PubMed Web of Science ®Google Scholar
• ATT CollaborationCollaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ20023247329718611786451
   PubMedGoogle Scholar
• CAPRIE Steering CommitteeA randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering CommitteeLancet19963489038132913398918275
   PubMed Web of Science ®Google Scholar
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) GroupLancet199835291318378539742976
   PubMed Web of Science ®Google Scholar
• RayKKSeshasaiSRWijesuriyaSEffect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trialsLancet200937396771765177219465231
   PubMed Web of Science ®Google Scholar
• SaccoRLDienerHCYusufSPRoFESS Study GroupAspirin and extended-release dipyridamole versus clopidogrel for recurrent strokeN Engl J Med2008359121238125118753638
   PubMed Web of Science ®Google Scholar
• WilleyJZMoonYPKahnEPopulation attributable risks of hypertension and diabetes for cardiovascular disease and stroke in the northern Manhattan studyJ Am Heart Assoc201435e00110625227406
   PubMed Web of Science ®Google Scholar
• PROGRESS Collaborative GroupRandomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attackLancet200135892871033104111589932
   PubMed Web of Science ®Google Scholar
• SPS3 Study GroupBenaventeORCoffeyCSBlood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trialLancet2013382989150751523726159
   PubMed Web of Science ®Google Scholar
• LawMRMorrisJKWaldNJUse of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studiesBMJ2009338b166519454737
   PubMed Web of Science ®Google Scholar
• AmarencoPBogousslavskyJCallahanA3rdStroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) InvestigatorsHigh-dose atorvastatin after stroke or transient ischemic attackN Engl J Med2006355654955916899775
   PubMed Web of Science ®Google Scholar
• AmarencoPBenaventeOGoldsteinLBStroke Prevention by Aggressive Reduction in Cholesterol Levels InvestigatorsResults of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial by stroke subtypesStroke20094041405140919228842
   PubMed Web of Science ®Google Scholar
• StamlerJVaccaroONeatonJDWentworthDDiabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention TrialDiabetes Care19931624344448432214
   PubMed Web of Science ®Google Scholar
• HolmanRRPaulSKBethelMAMatthewsDRNeilHA10-year follow-up of intensive glucose control in type 2 diabetesN Engl J Med2008359151577158918784090
   PubMed Web of Science ®Google Scholar
• Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research GroupNathanDMZinmanBModern-day clinical course of type 1 diabetes mellitus after 30 years’ duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983–2005)Arch Intern Med2009169141307131619636033
   PubMedGoogle Scholar
• Arauz-PachecoCParrottMARaskinPAmerican Diabetes AssociationTreatment of hypertension in adults with diabetesDiabetes Care200326Suppl 1S80S8212502624
   PubMedGoogle Scholar
• EstruchRRosEMartínez-GonzálezMAMediterranean diet for primary prevention of cardiovascular diseaseN Engl J Med2013369767667723944307
   PubMedGoogle Scholar
• WolfPAD’AgostinoRBKannelWBBonitaRBelangerAJCigarette smoking as a risk factor for stroke. The Framingham StudyJAMA19882597102510293339799
   PubMed Web of Science ®Google Scholar
• GageBFWatermanADShannonWBoechlerMRichMWRadfordMJValidation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial FibrillationJAMA2001285222864287011401607
   PubMed Web of Science ®Google Scholar
• LipGYNieuwlaatRPistersRLaneDACrijnsHJRefining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillationChest2010137226327219762550
   PubMed Web of Science ®Google Scholar
• CammAJLipGYDe CaterinaRESC Committee for Practice Guidelines-CPGDocument Reviewers2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation – developed with the special contribution of the European Heart Rhythm AssociationEuropace201214101385141322923145
   PubMed Web of Science ®Google Scholar
• ConnollySJEzekowitzMDYusufSRE-LY Steering Committee and InvestigatorsDabigatran versus warfarin in patients with atrial fibrillationN Engl J Med2009361121139115119717844
   PubMed Web of Science ®Google Scholar
• GrangerCBAlexanderJHMcMurrayJJARISTOTLE Committees and InvestigatorsApixaban versus warfarin in patients with atrial fibrillationN Engl J Med20113651198199221870978
   PubMed Web of Science ®Google Scholar
• PatelMRMahaffeyKWGargJROCKET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillationN Engl J Med20113651088389121830957
   PubMed Web of Science ®Google Scholar
• GiuglianoRPRuffCTBraunwaldEENGAGE AF-TIMI 48 InvestigatorsEdoxaban versus warfarin in patients with atrial fibrillationN Engl J Med2013369222093210424251359
   PubMed Web of Science ®Google Scholar
• AvecillaSTFerrellCChandlerWLReyesMPlasma-diluted thrombin time to measure dabigatran concentrations during dabigatran etexilate therapyAm J Clin Pathol2012137457257422431533
   PubMed Web of Science ®Google Scholar
• MillerCSGrandiSMShimonyAFilionKBEisenbergMJMetaanalysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillationAm J Cardiol2012110345346022537354
   PubMed Web of Science ®Google Scholar
• AlonsoABengtsonLGMacLehoseRFLutseyPLChenLYLakshminarayanKIntracranial hemorrhage mortality in atrial fibrillation patients treated with dabigatran or warfarinStroke20144582286229124994722
   PubMed Web of Science ®Google Scholar
• AnsellJEBakhruSHLaulichtBEUse of PER977 to reverse the anticoagulant effect of edoxabanN Engl J Med2014371222141214225371966
   PubMed Web of Science ®Google Scholar
• MorgensternLBHemphillJC3rdAndersonCGuidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke AssociationStroke20104192108212920651276
   PubMed Web of Science ®Google Scholar
• PistersRLaneDANieuwlaatRde VosCBCrijnsHJLipGYA novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart SurveyChest201013851093110020299623
   PubMed Web of Science ®Google Scholar
• SingerDEChangYBorowskyLHA new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk scoreJ Am Heart Assoc201323e00025023782923
   PubMed Web of Science ®Google Scholar
• ReddyVYHolmesDDoshiSKNeuzilPKarSSafety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access RegistryCirculation2011123441742421242484
   PubMed Web of Science ®Google Scholar
• HolmesDRJrKarSPriceMJProspective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trialJ Am Coll Cardiol201464111224998121
   PubMed Web of Science ®Google Scholar
• CannegieterSCRosendaalFRBriëtEThromboembolic and bleeding complications in patients with mechanical heart valve prosthesesCirculation19948926356418313552
   PubMed Web of Science ®Google Scholar
• NishimuraRAOttoCMBonowRO2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinesJ Thorac Cardiovasc Surg20141481e1e13224939033
   PubMed Web of Science ®Google Scholar
• EikelboomJWConnollySJBrueckmannMRE-ALIGN InvestigatorsDabigatran versus warfarin in patients with mechanical heart valvesN Engl J Med2013369131206121423991661
   PubMed Web of Science ®Google Scholar
• BrennanJMEdwardsFHZhaoYDEcIDE AVR (Developing Evidence to Inform Decisions about Effectiveness–Aortic Valve Replacement) Research TeamLong-term safety and effectiveness of mechanical versus biologic aortic valve prostheses in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National DatabaseCirculation2013127161647165523538379
   PubMed Web of Science ®Google Scholar
• JohannessenKANordrehaugJEvon der LippeGVollsetSERisk factors for embolisation in patients with left ventricular thrombi and acute myocardial infarctionBr Heart J19886021041103415869
   PubMedGoogle Scholar
• KerenAGoldbergSGottliebSNatural history of left ventricular thrombi: their appearance and resolution in the posthospitalization period of acute myocardial infarctionJ Am Coll Cardiol19901547908002307788
   PubMed Web of Science ®Google Scholar
• O’GaraPTKushnerFGAscheimDDAmerican College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice GuidelinesCirculation20131274e362e42523247304
   PubMed Web of Science ®Google Scholar
• HommaSThompsonJLSanfordARWARCEF InvestigatorsBenefit of warfarin compared with aspirin in patients with heart failure in sinus rhythm: a subgroup analysis of WARCEF, a randomized controlled trialCirc Heart Fail20136598899723881846
   PubMed Web of Science ®Google Scholar
• PullicinoPMQianMSaccoRLRecurrent stroke in the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trialCerebrovasc Dis201438317618125300706
   PubMed Web of Science ®Google Scholar
• MeierBFrankBWahlADienerHCSecondary stroke prevention: patent foramen ovale, aortic plaque, and carotid stenosisEur Heart J2012336705713713a713b22422912
   PubMed Web of Science ®Google Scholar
• Di TullioMRRussoCJinZSaccoRLMohrJPHommaSPatent Foramen Ovale in Cryptogenic Stroke Study InvestigatorsAortic arch plaques and risk of recurrent stroke and deathCirculation2009119172376238219380621
   PubMed Web of Science ®Google Scholar
• AmarencoPDavisSJonesEFClopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaquesStroke20144551248125724699050
   PubMed Web of Science ®Google Scholar
• FurieKLKasnerSEAdamsRJAmerican Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Clinical Cardiology, Interdisciplinary Council on Quality of Care and Outcomes ResearchGuidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke associationStroke201142122727620966421
   PubMed Web of Science ®Google Scholar
• CarrollJDSaverJLThalerDERESPECT InvestigatorsClosure of patent foramen ovale versus medical therapy after cryptogenic strokeN Engl J Med2013368121092110023514286
   PubMed Web of Science ®Google Scholar
• MeierBKalesanBMattleHPPC Trial InvestigatorsPercutaneous closure of patent foramen ovale in cryptogenic embolismN Engl J Med2013368121083109123514285
   PubMed Web of Science ®Google Scholar
• FurlanAJReismanMMassaroJCLOSURE I Investigators. Closure or medical therapy for cryptogenic stroke with patent foramen ovaleN Engl J Med20123661199199922417252
   PubMed Web of Science ®Google Scholar
• KentDMRuthazerRWeimarCAn index to identify stroke-related vs incidental patent foramen ovale in cryptogenic strokeNeurology201381761962523864310
   PubMed Web of Science ®Google Scholar
• North American Symptomatic Carotid Endarterectomy Trial CollaboratorsBeneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosisN Engl J Med199132574454531852179
   PubMed Web of Science ®Google Scholar
• FergusonGGEliasziwMBarrHWThe North American Symptomatic Carotid Endarterectomy Trial: surgical results in 1415 patientsStroke19993091751175810471419
   PubMed Web of Science ®Google Scholar
• RothwellPMEliasziwMGutnikovSACarotid Endarterectomy Trialists’ CollaborationAnalysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosisLancet2003361935210711612531577
   PubMed Web of Science ®Google Scholar
• PowersWJClarkeWRGrubbRLJrVideenTOAdamsHPJrDerdeynCPCOSS InvestigatorsExtracranial-intracranial bypass surgery for stroke prevention in hemodynamic cerebral ischemia: the Carotid Occlusion Surgery Study randomized trialJAMA2011306181983199222068990
   PubMed Web of Science ®Google Scholar
• EcksteinHHRinglebPAllenbergJRResults of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospective, randomised trialLancet Neurol200871089390218774746
   PubMed Web of Science ®Google Scholar
• International Carotid Stenting Study InvestigatorsEderleJDobsonJCarotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trialLancet2010375971998599720189239
   PubMed Web of Science ®Google Scholar
• Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis StudyJAMA199527318142114287723155
   PubMed Web of Science ®Google Scholar
• HallidayAMansfieldAMarroJMRC Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trialLancet200436394201491150215135594
   PubMed Web of Science ®Google Scholar
• BrottTGCarotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial (CREST-2)ClinicalTrials.gov [website on the Internet]Bethseda, MDUS National Library of Medicine2014 [updated May 27, 2015]. Available from: https://clinicaltrials.gov/ct2/show/NCT02089217. NLM identifier: NCT02089217Accessed April 14, 2015
   Google Scholar
• DerdeynCPChimowitzMILynnMJStenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial InvestigatorsAggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trialLancet2014383991433334124168957
   PubMed Web of Science ®Google Scholar
• WangYWangYZhaoXCHANCE InvestigatorsClopidogrel with aspirin in acute minor stroke or transient ischemic attackN Engl J Med20133691111923803136
   PubMed Web of Science ®Google Scholar
• JohnstonSCEastonJDFarrantMPlatelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and designInt J Stroke20138647948323879752
   PubMed Web of Science ®Google Scholar
• Sevush-GarcyJGutierrezJAn epidemiological perspective on race/ethnicity and strokeCurr Cardiovasc Risk Rep2015919
   Google Scholar
• No authors listedThe European Stroke Prevention Study (ESPS). Principal end-points. The ESPS GroupLancet198728572135113542890951
   PubMed Web of Science ®Google Scholar
• No authors listedCAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative GroupLancet19973499066164116499186381
   PubMed Web of Science ®Google Scholar
• No authors listedThe International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative GroupLancet19973499065156915819174558
   PubMed Web of Science ®Google Scholar
• BousserMGEschwegeEHaguenauM“AICLA” controlled trial of aspirin and dipyridamole in the secondary prevention of atherothrombotic cerebral ischemiaStroke19831415146401878
   PubMed Web of Science ®Google Scholar
• DienerHCBogousslavskyJBrassLMAspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trialLancet2004364943133133715276392
   PubMed Web of Science ®Google Scholar
• DienerHCCunhaLForbesCSiveniusJSmetsPLowenthalAEuropean Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of strokeJ Neurol Sci19961431-21138981292
   PubMed Web of Science ®Google Scholar
• FarrellBGodwinJRichardsSWarlowCThe United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final resultsJ Neurol Neurosurg Psychiatry19915412104410541783914
   PubMed Web of Science ®Google Scholar
• ESPRIT Study GroupHalkesPHvan GijnJKappelleLJKoudstaalPJAlgraAAspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trialLancet200636795231665167316714187
   PubMed Web of Science ®Google Scholar
• EAFT (European Atrial Fibrillation Trial) Study GroupSecondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor strokeLancet19933428882125512627901582
   PubMed Web of Science ®Google Scholar